-
Product Insights
NewCXXC Type Zinc Finger Protein 5 – Drugs In Development, 2024
The CXXC Type Zinc Finger Protein 5 pipeline drugs market research report outlays comprehensive information on the CXXC Type Zinc Finger Protein 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Dermatology, Gastrointestinal, and Musculoskeletal Disorders which include indications of Diabetes, Obesity, Wounds, Diabetic Foot Ulcers, Metabolic Dysfunction-Associated Steatohepatitis (MASH), and Osteoporosis. It also reviews...
-
Product Insights
NewNicotinamide N Methyltransferase – Drugs In Development, 2024
The Nicotinamide N Methyltransferase pipeline drugs market research report outlays comprehensive information on the Nicotinamide N Methyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders, Metabolic Disorders, Oncology, and Gastrointestinal which include indications of Musculoskeletal Disorders, Sarcopenia, Obesity, Type 2 Diabetes, Solid Tumor, Glioblastoma Multiforme (GBM), and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key...
-
Product Insights
NewMethionine Aminopeptidase – Drugs In Development, 2024
The Methionine Aminopeptidase pipeline drugs market research report outlays comprehensive information on the Methionine Aminopeptidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Metabolic Disorders, Genito Urinary System, and Respiratory which include indications of Prostate Cancer, Melanoma, Metabolic Disorders, Obesity, Urinary Tract Infections, and Idiopathic Pulmonary Fibrosis. It also reviews key players involved in Methionine Aminopeptidase...
-
Product Insights
NewInterleukin 22 Receptor – Drugs In Development, 2024
The Interleukin 22 Receptor pipeline drugs market research report outlays comprehensive information on the Interleukin 22 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Immunology, Metabolic Disorders, and Infectious Disease which include indications of Ulcerative Colitis, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Psoriasis, Autoimmune Disorders, Obesity, Type 2 Diabetes, Human Immunodeficiency Virus (HIV) Infections (AIDS), and Coronavirus...
-
Product Insights
NewReceptor Activity Modifying Protein 1 – Drugs In Development, 2024
The Receptor Activity Modifying Protein 1 pipeline drugs market research report outlays comprehensive information on the Receptor Activity Modifying Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key players involved in Receptor Activity Modifying Protein...
-
Product Insights
NewReceptor Activity Modifying Protein 2 – Drugs In Development, 2024
The Receptor Activity Modifying Protein 2 pipeline drugs market research report outlays comprehensive information on the Receptor Activity Modifying Protein 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key players involved in Receptor Activity Modifying Protein...
-
Product Insights
NewReceptor Activity Modifying Protein 3 – Drugs In Development, 2024
The Receptor Activity Modifying Protein 3 pipeline drugs market research report outlays comprehensive information on the Receptor Activity Modifying Protein 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key players involved in Receptor Activity Modifying Protein...
-
Product Insights
NewStearoyl CoA Desaturase – Drugs In Development, 2024
The Stearoyl CoA Desaturase pipeline drugs market research report outlays comprehensive information on the Stearoyl CoA Desaturase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Oncology, Central Nervous System, and Metabolic Disorders which include indications of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Colorectal Cancer, Colon Cancer, Lewy Body Dementia, Parkinson's Disease, Obesity,...
-
Product Insights
NewC-X-C Chemokine Receptor Type 1 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Metastatic Colorectal Cancer, Solid Tumor, Psoriasis, Inflammation, Obesity, Type 1 Diabetes (Juvenile Diabetes), and Hidradenitis Suppurativa. It also...
-
Product Insights
NewLeptin Receptor – Drugs In Development, 2024
The Leptin Receptor pipeline drugs market research report outlays comprehensive information on the Leptin Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Central Nervous System, Oncology, and Respiratory which include indications of Obesity, Lipodystrophy (Lipoatrophy), Alzheimer's Disease, Sleep Disorders, Solid Tumor, and Obstructive Sleep Apnea. It also reviews key players involved in Leptin Receptor...